Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients

Clinical Microbiology Reviews

Volumn 17, Issue 4, 2004, Pages 770-782

  Rodriguez, Martin ^a   Fishman, Jay A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTIFUNGAL AGENT; ATOVAQUONE; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLINDAMYCIN; COTRIMOXAZOLE; CYCLOSPORIN A; DAPSONE; EFLORNITHINE; FANSIDAR; FOLINIC ACID; GANCICLOVIR; MACROLIDE; MALOPRIM; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OFLOXACIN; PENTAMIDINE; PENTAMIDINE ISETHIONATE; PIRITREXIM; PRIMAQUINE; PYRIMETHAMINE; SALBUTAMOL; SULFAMETHOXAZOLE; SULFONAMIDE; TACROLIMUS; TRIMETHOPRIM; TRIMETREXATE; UNINDEXED DRUG;

AEROSOL; AGRANULOCYTOSIS; ANAPHYLAXIS; ANTIBIOTIC PROPHYLAXIS; APLASTIC ANEMIA; BLOOD TOXICITY; BRONCHOSPASM; CELLULAR IMMUNITY; COUGHING; DESQUAMATION; DIARRHEA; DISEASE PREDISPOSITION; DRUG COST; DRUG HALF LIFE; DRUG METABOLISM; FEVER; HEADACHE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYTIC ANEMIA; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; HYPERKALEMIA; HYPOGLYCEMIA; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; LYMPHADENOPATHY; MALAISE; MALIGNANT NEOPLASTIC DISEASE; MENINGITIS; METHEMOGLOBINEMIA; NAUSEA; NEPHRITIS; NEPHROTOXICITY; NEUTROPENIA; PANCYTOPENIA; PNEUMOCYSTIS; PNEUMOCYSTOSIS; RASH; REVIEW; VOMITING; WHEEZING;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; BONE MARROW TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; PENTAMIDINE; PNEUMOCYSTIS INFECTIONS; SULFAMETHOXAZOLE; SURVIVAL RATE; TRIMETHOPRIM;

FUNGI; HUMAN IMMUNODEFICIENCY VIRUS; PNEUMOCYSTIS; PROTOZOA;

EID: 5644300856     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.17.4.770-782.2004     Document Type: Review

References (177)

1. Absar, N. H. Daneshvar, and G. Beall. 1994. Desensitization to trimethoprim-sulfamethoxazole in HIV-infected patients. J. Allergy Clin. Immunol. 93:1001-1005.
2. Antinori, A., R. Murri, A. Ammassari, A. De Luca, A. Linzalone, D. F. Cingolani, G. Maluro, J. Vecchiet, and G. Scoppettuolo. 1996. Aerosolized pentamidine, co-trimoxazole and dapsone-pyrimethamine for primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis. AIDS 10:1045-1046.
3. Arend, S. M., F. P. Kroon, and J. W. van't Wout. 1995. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. Arch. Intern. Med. 155:2435-2441.
4. Arend, S. M., G. J. Westendrop, F. P. Kroon, J. W. van't Wout, L. A. Vandenbroucke, L. A. van Es, and F. J. van der Woude. 1996. Rejection treatment and cytomegalovirus infection as a risk factor for Pneumocystis carinii pneumonia in renal transplant recipients. Clin. Infect. Dis. 22:920-925.
5. Baggish, A. L., and D. R. Hill. 2002. Antiparasitic agent atovaquone. Antimicrob. Agents Chemother. 46:1163-1173.
6. Barber, B. A., P. S. Pegram, and K. P. High. 1996. Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia. Clin. Infect. Dis. 23:718-722.
7. Bartlett, M. S., T. D. Edlind, C. H. Lee, R. Dean, S. F. Queener, M. M. Shaw, and J. W. Smith. 1994. Albendazole inhibits Pneumocystis carinii proliferation in inoculated immunosuppressed mice. Antimicrob. Agents Chemother. 38:1834-1837.
8. Bartlett, M. S., J. A. Fishman, M. M. Durkin, S. F. Queener, and J. W. Smith. 1988. Pneumocystis carinii: improved models to study efficacy of drugs for the treatment on prophylaxis of Pneumocystis pneumonia. Exp. Parasitol. 70:100-106.
9. Beck, J. M., H. D. Liggitt, E. N. Brunette, H. J. Fuchs, J. E. Shellito, and R. J. Debs. 1991. Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infect. Immun. 59:3859-3862.
10. Beck-Sague, C., S. W. Dooley, M. D. Huton, J. Otten, A. Breeden, J. T. Crawford, A. E. Pitchenik, C. Woodley, G. Cauthen, and W. R. Jarvis. 1992. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infection. JAMA 268:1280-1286.
11. Bozzette, S. A., D. M. Finkelstein, S. A. Spector, P. Frame, W. G. Powderly, W. He, L. Phillips, D. Craven, C. van der Horst, and J. Feinberg. 1995. A randomized trial of three anti-Pneumocystis agents in patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 332:693-699.
12. Branten, A. J., P. J. Beckers, R. G. Tiggeler, and A. J. Hoitsma. 1995. Pneumocystis carinii pneumonia in renal transplant recipients. Nephrol. Dial. Transplant. 10:1194-1197.
13. Broaddus, C., M. D. Dake, M. S. Stulbarg, W. Blumenfeld, W. K. Hadley, J. A. Golden, and P. C. Hopewell. 1985. Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome. Ann. Intern. Med. 102:747-752.
14. Browne, M. J., S. M. Hubbard, D. L. Longo, R. Fisher, R. Wesley, D. C. Ihde, R. C. Young, and P. A. Pizzo. 1986. Excess prevalence of Pneumocystis carinii pneumonia in patients treated for lymphoma with combination chemotherapy. Ann. Intern. Med. 104:338-344.
15. Burke, B. A., and R. A. Good. 1992. Pneumocystis carinii infection. Medicine 71:165-175.
16. Caliendo, A. M., P. L. Hewitt, J. M. Allega, A. Keen, K. L. Ruoff, and M. J. Ferraro. 1998. Performance of a PCR assay for detection of Pneumocystis carinii from respiratory specimens. J. Clin. Microbiol. 36:979-982.
17. Carr, A., R. Penny, and D. A. Cooper. 1993. Efficacy and safety of rechallenge with low-dose trimethoprim-sulfamethoxazole in previously hypersensitive HIV-infected patients. AIDS 7:65-71.
18. Castagnola, E., G. Dini, E. Lanino, L. Tasso, S. Dallorso, A. Garaventa, G. A. Rossi, and R. Giacchino. 1995. Low CD4 count in a patient with Pneumocystis carinii pneumonia after autologous bone marrow transplantation. Bone Marrow Transplant. 15:977-978.
19. Centers for Disease Control. 1990. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, with special focus on HIV-related issues. Morb. Mortal. Wkly. Rep. 39:1-29.
20. Chan, C., J. Montaner, E. A. Lefebvre, G. Morey, M. Dohn, A. McIvor, J. Scott, R. Marina, and P. Caldwell. 1999. Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides. J. Infect. Dis. 180:369-376.
21. Chave, J. P., S. David, J. P. Wauters, G. Van Melle, and P. Francioli. 1991. Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia among renal transplant recipients. AIDS 5:927-932.
22. Chevrel, G., J. F. Brantus, J. Sainte-Laudy, and P. Miossec. 1999. Allergic pancytopenia to trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia following methotrexate treatment for rheumatoid arthritis. Rheumatology 38:475-476.
23. Chung, J. B., K. Armstrong, J. S. Schwartz, and D. Albert. 2000. Cost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis undergoing immunosuppressive therapy. Arthritis Rheum. 43:1841-1848.
24. Cirioni, O., A. Giacometti, M. Quarta, and G. Scalise. 1997. In-vitro activity of topoisomerase inhibitors against Pneumocystis carinii. J. Antimicrob. Chemother. 40:583-586.
25. Cirioni, O., A. Giacometti, and G. Scalise. 1997. In-vitro activity of atovaquone, sulphamethoxazole and dapsone alone and combined with inhibitors of dihydrofolate reductase and macrolides against Pneumocystis carinii. J. Antimicrob. Chemother. 39:45-51.
26. Colby, C., S. L. McAfee, R. Sackstein, D. M. Finkelstein, J. A. Fishman, and T. R. Spitzer. 1999. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole for Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 24:897-902.
27. Colombo, J. L., P. H. Sammut, A. N. Langnas, and B. W. Shaw, Jr. 1992. The spectrum of Pneumocystis carinii infection after liver transplantation in children. Transplantation 54:621-624.
28. Contini, C., E. Angelici, and R. Canipari. 1999. Structural changes in rat Pneumocystis carinii surface antigens after terbinafine administration in experimental Pneumocystis carinii pneumonia. J. Antimicrob. Chemother. 43:301-304.
29. Cross, A. S., and R. T. Steigbigel. 1974. Pneumocystis carinii pneumonia presenting as localized nodular densities. N. Engl. J. Med. 291:832-832.
30. Decker, C. F., and H. Masur. 2002. Pneumocystis carinii, p. 1111-1121. In V. L. Yu, R. Weber, D. Raoult (ed.), Antimicrobial therapy and vaccines. Apple Tree Productions, Inc., New York, N.Y.
31. Doppman, J. L., and G. W. Geelhoed. 1976. Atypical radiographic features in Pneumocystis carinii pneumonia. NCI Monogr. 43:89-97.
32. Dummer, J. S., C. G. Montero, B. P. Griffith, R. L. Hardesty, I. L. Paradis, and M. Ho. 1986. Infections in heart-lung transplant recipients. Transplantation 41:725-729.
33. Dykewicz, C. A., Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society of Blood and Marrow Transplantation. 2001. Summary of the guidelines for prevention of opportunistic infections among hematologic stem cell transplant recipients. Clin. Infect. Dis. 33:139-144.
34. Edman, J. C., J. A. Kovacs, H. Masur, D. V. Santi, H. J. Elwood, and M. L. Sogin. 1988. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 334:519-521.
35. El-Sadr, W. M., R. Luskin-Hawk, T. M. Yurik, J. Walker, D. Abrams, S. L. John, R. Sherer, L. Crane, A. Labriola, S. Caras, C. Pulling, and R. A. Hafner. 1998. A randomized trial of daily and thrice-weekly trimethoprim- sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Clin. Infect. Dis. 29:775-783.
36. El-Sadr, W. M., R. L. Murphy, T. M. Yurik, R. Luskin-Hawk, T. W. Cheung, H. H. Balfour, R. Eng, T. M. Hooton, T. M. Kerkering, M. Schutz, C. van der Horst, and R. Hafner. 1998. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. N. Engl. J. Med. 339:1889-1895.
37. Ena, J., C. Amador, F. Pasquau, C. Carbonell, C. Benito, F. Gutierrez, and A. Vilar. 1994. Once-a month administration of intravenous pentamidine to patients infected with human immunodeficiency virus as prophylaxis for Pneumocystis carinii pneumonia. Clin. Infect. Dis. 18:901-904.
38. Fischl, M. A., and G. M. Dickinson. 1986. Fansidar prophylaxis of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann. Intern. Med. 105:629.
39. Fischl, M. A., G. M. Dickinson, and L. La Voie. 1988. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA 259:1185-1189.
40. Fishman, J. A. 2002. Pneumocystis carinii and parasitic infections in the immunocompromised host. p. 265-334. In R. H. Rubin, S. Y. Lowell (ed.), Clinical approach to infection in the compromised host. Kluwer Academic/Plenum Publishers, New York, N.Y.
41. Fishman, J. A. 2001. Prevention of infection caused by Pneumocystis carinii in transplant recipients. Clin. Infect. Dis. 33:1397-1405.
42. Fishman, J. A. 1998. Prevention of infection due to Pneumocystis carinii. Antimicrob. Agents Chemother. 42:995-1004.
43. Fishman, J. A., S. F. Queener, R. S. Roth, and M. S. Bartlett. 1993. Activity of topoisomerase inhibitors against Pneumocystis carinii in vitro and in an inoculated mouse model. Antimicrob. Agents Chemother. 37:1543-1546.
44. Foot, A. B., Y. J. Garin, P. Ribaud, A. Devergie, F. Derouin, and E. Gluckman. 1994. Prophylaxis of toxoplasmosis infection with pyrimethamine/ sulfadoxine in bone marrow transplant recipients. Bone Marrow Transplant. 14:241-245.
45. Gajdusek, D. C. 1957. Pneumocystis carinii-etiologic agent of interstitial plasma cell pneumonia of premature and young infants. Pediatrics 19:543-565.
46. Gerrard, J. G. 1995. Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults. Med. J. Aust. 162:233-235.
47. Gigliotti, F., and W. T. Hughes. 1988. Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. J. Clin. Investig. 81:1666-1668.
48. Girard, P. M., R. Landman, C. Gaudebout, R. Olivares, A. G. Saimot, P. Jelazko, C. Gaudebout, A. Certain, F. Boue, E. Bouvet, T. Lecompte, and J. P. Coulaud. 1993. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N. Engl. J. Med. 328:1514-1520.
49. Girard, P. M., A. Lepetre, P. Detruchis, S. Matheron, and J. P. Coulaud. 1989. Failure of pyrimethamine-clindamycin combination for prophylaxis of Pneumocystis carinii pneumonia. Lancet i:1459.
50. Gluck, T., H. F. Geerdes-Fenge, R. H. Starub, M. Raffenberg, B. Lang, H. Lode, and J. Scholmerich. 2000. Pneumocystis carinii pneumonia as a complication of immunosuppressive therapy. Infection 28:227-230.
51. Gluckstein, D., and J. Ruskin. 1995. Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SXZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SXZ. Clin. Infect. Dis. 20:849-853.
52. Godeau, B., V. Coutant-Perronne, D. L. T. Huoung, L. Guillevin, G. Magadur, M. De Bant, S. Dellion, J. Rossert, G. Rostoker, J. C. Piette, and A. Schaeffer. 1994. Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J. Rheumatol. 21:246-251.
53. Godeau, B., J. L. Mainardi, F. Roudot-Thoraval, E. Hachulla, L. Guillevin, L. T. Huong Du, B. Jarrousse, P. Remy, A. Schaeffer, and J. C. Piette. 1995. Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis. Ann. Rheum. Dis. 54:991-994.
54. Golden, J. A., A. Sjoerdsma, and D. V. Santi. 1984. Pneumocystis carinii pneumonia treated with alpha-difluoromethylornithine. West. J. Med. 141:613-623.
55. Goodell, B., J. B. Jacobs, R. D. Powell, and V. T. DeVita. 1970. Pneumocystis carinii: The spectrum of diffuse interstitial pneumonia in patients with neoplastic diseases. Ann. Intern. Med. 72:337-340.
56. Gordon, S. M., S. P. LaRosa, S. Kalmadi, A. C. Arroliga, R. K. Avery, L. Truesdell-LaRosa, and D. L. Longworth. 1999. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin. Infect. Dis. 28:240-246.
57. Gryzan, S., I. L. Paradis, A. Zeevi, R. J. Duquesnoy, J. S. Dummer, B. P. Griffith, R. L. Hardesty, A. Trento, M. A. Nalesnik, and J. H. Dauber. 1988. Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Am. Rev. Respir. Dis. 137:1268-1274.
58. Hardy, A. M., C. P. Wajszczuk, A. F. Suffredini, T. R. Hakala, and M. Ho. 1984. Pneumocystis carinii pneumonia in renal transplant recipients treated with cyclosporine and steroids. J. Infect. Dis. 149:143-147.
59. Hardy, W. D., J. Feinberg, D. M. Finkelstein, M. E. Power, W. He, C. Kaczka, P. T. Frame, M. Holmes, H. Waskin, R. J. Pass, W. G. Powderly, R. T. Steigbigel, A. Zuger, and R. S. Holzman. 1992. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. N. Engl. J. Med. 327:1842-1848.
60. Hardy, W. D., D. W. Northfelt, and T. A. Drake. 1989. Fatal, disseminated pneumocystosis in a patient with acquired immunodeficiency syndrome receiving prophylactic aerosolized pentamidine. Am. J. Med. 87:329-331.
61. Hayes, M. J., P. J. Torzillo, A. G. R. Sheil, and G. W. McCaughan. 1994. Pneumocystis carinii pneumonia after liver transplantation in adults. Clin. Transplant. 8:499-503.
62. Heald, A., M. Flepp, J. P. Chave, R. Malinverni, S. Ruttimann, V. Gabriel, C. Renold, A. Sugar, and B. Hirschel. 1991. Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study. Ann. Intern. Med. 115:760-763.
63. Helweg-Larsen, J., T. L. Benfield, J. Eugen-Olsen, J. D. Lundgren, and B. Lundgren. 1999. Effect of mutations of Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated Pneumocystis carinii pneumonia. Lancet 354:1347-1351.
64. Hennequin, C., B. Page, P. Roux, C. Legendre, and H. Kreis. 1995. Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit. Eur. J. Clin. Microbiol. Infect. Dis. 14:122-126.
65. Henson, J. W., J. K. Jalaj; R. W. Walker, D. E. Stover, and A. O. S. Fels. 1991. Pneumocystis carinii pneumonia in patients with primary brain tumors. Arch. Neurol. 48:406-409.
66. Higgins, R. M., S. L. Bloom, J. M. Hopkin, and P. J. Morris. 1989. The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation. Transplantation 47:558-560.
67. Hoffman, G. S., G. S. Kerr, R. Y. Leavitt, C. W. Hallahan, W. D. Travis, M. Rottem, and A. S. Fauci. 1992. Wegener granulomatosis: an analysis of 158 patients. Ann. Intern. Med. 116:488-4198.
68. Huang, L., C. B. Beard, J. Creasman, D. Levy, J. S. Duchin, S. Lee, N. Pieniazek, J. L. Carter, C. del Rio, D. Rimland, and T. R. Navin. 2000. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J. Infect. Dis. 182:1192-1198.
69. Hughes, W. T. 1984. Five-year absence of Pneumocystis carinii pneumonitis in a pediatric oncology center. J. Infect. Dis. 150:305-306.
70. Hughes, W. T. 1987. Pneumocystis carinii pneumonia. CRC Press Inc., Boca Raton, Fla.
71. Hughes, W. T. 1998. Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: a review. Clin. Infect. Dis. 27:191-204.
72. Hughes, W. T. 2003. Pneumocystis carinii vs Pneumocystis jiroveci: another misnomer. Emerg. Infect. Dis. 9:276-277.
73. Hughes, W. T., S. Feldman, R. J. A. Aur, M. S. Verzosa, O. Hustu, and J. V. Simone. 1975. Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis. Cancer 36:2004-2009.
74. Hughes, W. T., S. Feldman, S. C. Chaudhary, M. J. Ossi, F. Cox, and S. K. Sanyal. 1978. Comparison of pentamidine isethionate and trimethoprim- sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. J. Pediatr. 92:285-291.
75. Hughes, W. T., and W. W. Johnson. 1971. Recurrent Pneumocystis carinii pneumonia following apparent recovery. J. Pediatr. 79:755-759.
76. Hughes, W. T., S. Kuhn, S. Chaudhary, S. Feldman, M. Verzosa, R. J. A. Aur, C. Pratt, and S. L. George. 1977. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N. Engl. J. Med. 297:1419-1426.
77. Hughes, W. T., G. Leoung, F. Kramer, S. A. Bozzette, S. Safrin, P. Frame, N, Clumeck, H. Masur, D. Lancaster, and C. Chan. 1993. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. N. Engl. J. Med. 328:1521-1527.
78. Hughes, W. T., R. A. Price, H. K. Kim, T. P. Coburn, D. Girgsby, and S. Feldman. 1973. Pneumocystis carinii pneumonitis in children with malignancies. J. Pediatr. 82:404-415.
79. Hughes, W. T., G. K. Rivera, M. J. Schell, D. Thornton, and L. Lott. 1987. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N. Engl. J. Med. 316:1627-1632.
80. Imrie, K. R., H. M. Prince, F. Couture, J. M. Brandwein, and A. Keating. 1995. Effect of antimicrobial prophylaxis on hematopoietic recovery following autologous bone marrow transplantation: ciprofloxacin versus co-trimoxazole. Bone Marrow Transplant. 15:267-270.
81. Ioannidis, J. P. A., J. C. Cappelleri, P. R. Skolnik, J. Lau, and H. S. Sacks. 1996. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimen. Arch. Intern. Med. 156:177-188.
82. Ito, M., R. Nozu, T. Kuramochi, N. Eguchi, S. Suzuki, K. Hioki, T. Itoh, and F. Ikeda. 2000. Prophylactic effect of FK-463, a novel antifungal lipopeptide, against Pneumocystis carinii infection in mice. Antimicrob. Agents Chemother. 44:2259-2262.
83. Janner, D., J. Bork, M. Baum, and R. Chinnock. 1996. Pneumocystis carinii pneumonia in infants after heart transplantation. J. Heart Lung Transplant. 15:758-763.
84. Jimenez, E., A. Martinez, E. M. Aliouat, J. Caballero, E. Dei-Cas, and D. Gargallo-Viola. 2002. Therapeutic efficacies of GW471552 and GW 471558, two new azasordarin derivatives, against pneumocystosis in two imunosuppressed-rat models. Antimicrob. Agents Chemother. 46:2648-2650.
85. Jirovec, O. 1952. Pneumocystis carinii puvodce t. zv intertitialnich plasmocelularnich pneumonii kojencw Csl. Hyg. Epidemiol Mikrobiol. 1:141.
86. Jorde, U. P., H. W. Horowitz, and G. P. Wormser. 1993. Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim- sulfamethoxazole intolerant, HIV-infected individuals. AIDS 7:355-359.
87. Jules-Elysee, K. M., D. E. Stover, M. B. Zaman, E. M. Bernard, and D. A. White. 1990. Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia. Ann. Intern. Med. 112:750-757.
88. Kadoya, A., J. Okada, Y. Iikuni, and H. Kondo. 1996. Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus. J. Rheumatol. 23:1186-1188.
89. Kazanjian, P., W. Armstrong, P. A. Hossler, W. Burman, J. Richardson, C. H. Lee, L. Crane, J. Katz, and S. R. Meshnick. 2000. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J. Infect. Dis. 182:551-557.
90. Kazanjian, P., W. Armstrong, P. A. Hossler, L. Huang, C. B. Beard, J. Carter, L. Crane, J. Duchin, W. Burman, J. Richardson, and S. R. Meshnick. 2001. Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS. j. Infect. Dis. 183:819-822.
91. Kazanjian, P., A. B. Locke, P. A. Hossler, B. R. Lane, M. S. Bartlett, J. W. Smith, M. Cannon, and S. R. Meshnick. 1998. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients. AIDS 12:873-878.
92. Kovacs, J. A., J. W. Hiemenz, A. M. Macher, D. Stover, H. W. Murray, J. Shelhamer, H. C. Lane, C. Urmacher, C. Honig, D. L. Longo, M. M. parker, C. Natanson, J. E. Parrillo, A. S. Fauci, P. A. Pizzo, and H. Masur. 1984. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann. Intern. Med. 100:663-671.
93. Kovacs, J. A., V. L. Ng, H. Masur, G. Leoung, W. K. Hadley, G. Evans, H. C Lane, F. P. Ognibene, J. Shelhamer, and J. E. Parrillo. 1988. Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. N. Engl. J. Med. 318:589-593.
94. Kroesen, S., A. F. Widmer, A. Tyndall, and P. Hasler. 2003. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-α therapy. Rheumatology 42:617-621
95. Kulke, M. H., and E. A. Vance. 1997. Pneumocystis carinii pneumonia in patients receiving chemotherapy for breast cancer. Clin. Infect. Dis. 25:215-218.
96. LaRocque, R. C., J. L. Katz, P. Perruzzi, and L. R. Baden. 2003. The utility of sputum induction for diagnosis of Pneumocystis pneumonia in immunocompromised patients without human immunodeficiency virus. Clin. Infect. Dis. 37:1380-1383.
97. La Touche, S., J. L. Poirot, C. Bernard, and P. Roux. 1997. Study of internal transcribed spacer and mitochondrial large-subunit genes of Pneumocystis carinii hominis isolated from repeated bronchoalveolar lavage form human immunodeficiency virus-infected patients during one or several episodes of pneumonia. J. Clin. Microbiol. 35:1687-1690.
98. Lau, W. K., L. S. Young, and J. S. Remington. 1976. Pneumocystis carinii pneumonia: diagnosis by examination of pulmonary secretions. JAMA 236:2399-2402.
99. Leggiadro, R. J., J. A. Winkelstein, and W. T. Hughes. 1981. Prevalence of Pneumocystis carinii pneumonitis in severe combined immunodeficiency. J. Pediatr. 99:96-98.
100. Leoung, G. S., J. F. Stanford, M. F. Giordano, A. Stein, R. A. Torres, C. A. Giffen, M. Wesley, T. Sarracco, E. C. Cooper, V. Dratter, J. J. Smith, and K. R. Frost. 2001. Trimethoprim-sulfamethoxazole (TMP-SXZ) dose escalation versus direct rechallenge for Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SXZ. J. Infect. Dis. 184:992-997.
101. Lew, M. A., K. Kehoe, J. Ritz, K. H. Antman, L. Nadler, L. A. Kalish, and R. Finberg. 1995. Ciprofloxacin versus trimethoprim-sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial. J. Clin. Oncol. 13:239-250.
102. Limper, A. H., K. P. Offord, T. F. Smith, and W. J. Martin. 1989. Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am. Rev. Respir. Dis. 140:1204-1209.
103. Lu, J., M. S. Bartlett, M. Shaw, S. Queener, J. W. Smith, M. Ortiz-Rivera, M. Leibowitz, and C. H. Lee. 1994. Typing of Pneumocystis carinii strains that infect humans based on nucleotide sequence variations of internal transcribed spacers of rRNA genes. J. Clin. Microbiol. 32:2904-2912.
104. Lufft, V., V. Kliem, M. Behrend, R. Pichlmyer, K. M. Koch, and R. Brunkhorst. 1996. Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. Transplantation 62:421-423.
105. Lyytikäinen, O., T. Ruutu, L. Volin, I. Lautenschlager, L. Jokipii, L. Tiittanen, and P. Ruutu. 1996. Late onset of Pneumocystis carinii pneumonia following allogeneic bone marrow transplantation. Bone Marrow Transplant. 17:1057-1059.
106. Maltezou, H. C., D. Petropoulos, M. Choroszy, M. Gardner, E. C. Mantzouranis, K. V. I. Rolston, and K. W. Chan. 1997. Dapsone for Pneumocystis carinii prophylaxis in children undergoing bone marrow transplantation. Bone Marrow Transplant. 20:879-881.
107. + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. Chest 118:712-720.
108. Masur, H. 1992. Prevention and treatment of Pneumocystis carinii Pneumocystis carinii pneumonia. N. Engl. J. Med. 327:1853-1860.
109. Masur, H., J. E. Kaplan, K. K. Holmes, U.S. Public Health Service, and Infectious Diseases Society of America. 2002. Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. Ann. Intern. Med. 137:435-478.
110. Masur, H., F. P. Ognibene, R. Yarchoan, J. H. Shelhamer, B. F. Baird, V. Travis, A. F. Suffredini, L. Deyton, J. A. Kovacs, and J. Falloon. 1989. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann. Intern. Med. 111:223-231.
111. Mei, Q., S. Gurunathan, H. Masur, and J. A. Kovacs. 1998. Failure of co-trimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene. Lancet 351:1631-1632.
112. Meyers, B., F. Borrego, and G. Papanicolau. 2001. Pneumocystis carinii pneumonia prophylaxis with atovaquone in trimethoprim-sulfamethoxazole- intolerant orthotopic liver transplant patients: a preliminary study. Liver Transplant.. 7:750-751.
113. Meyers, J. D., N. Flournoy, and E. D. Thomas. 1982. Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev. Infect. Dis. 4:1119-1132.
114. Mohle-Boetani, J., S. K. Akula, M. Holodniy, D. Katzenstain, and G. Garcia. 1992. The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia. West. J. Med. 156:303-306.
115. Montaner, J. S., L. M. Lawson, A. Gervais, R. H. Hyland, C. K. Chan, J. M. Falutz, P. M. Renzi, D. MacFadden, A. R. Rachlis, and I. W. Fong. 1991. Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia. A randomized, placebo controlled study. Ann. Intern. Med. 114:948-953.
116. Munoz, P., R. M. Munoz, J. Palomo, M. Rodriguez-Creixems, R. Munoz, and E. Bouza. 1997. Pneumocystis carinii infection in heart transplant recipients. Medicine 76:415-422.
117. Mustafa, M. M., A. Pappo, J. Cash, N. J. Winick, and G. R. Buchanan. 1994. Aerosolized pentamidine for the prevention of Pneumocystis carinii pneumonia in children with cancer intolerant or allergic to trimethoprim/ sulfamethoxazole. J. Clin. Oncol. 12:258-261.
118. Nahimana, A., M. Rabodonirina, G. Zanetti, I. Meneau, P. Francioli, J. Bille, and P. M. Hauser. 2003. Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/ sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients. J. Infect. Dis. 188:1017-1023.
119. Nathan, S. D., D. J. Ross, P. Zakowski, R. M. Kass, and S. K. Koerner. 1994. Utility of inhaled pentamidine prophylaxis in lung transplant recipients. Chest 105:417-420.
120. Navin, T. R., C. B. Beard, L. Huang, C. del Rio, S. Lee, N. J. Pieniazek, J. L. Carter, T. Le, A. Hightower, and D. Rimland. 2001. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of Pneumocystis carinii pneumonia in patients with HIV-1: a prospective study. Lancet 358:545-549.
121. Nüesch, R., C. Bellini, and W. Zimmerli. 1999. Pneumocystis carinii pneumonia in human immunodeficiency virus (HIV)-positive and HIV-negative immunocompromised patients. Clin. Infect. Dis. 29:1519-1523.
122. Ognibene, F. P., J. H. Shelhamer, G. S. Hoffman, G. S. Kerr, D. Reda, A. S. Fauci, and R. Y. Leavitt. 1995. Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. Am. J. Respir. Crit. Care Med. 151:795-799.
123. Okada, J., A. Kadoya, M. Rana, A. Ishikawa, Y. Iikuni, and H. Kondo. 1999. Efficacy of sulfamethoxazole-trimethoprim administration in the prevention of Pneumocystis carinii pneumonia in patients with connective tissue disease. Kansenshogaku Zasshi 73:1123-1129.
124. Okuda, Y., T. Oyama, H. Oyama, T. Miyamoto, and K. Takasugi. 1995. Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for malignant rheumatoid arthritis. Ryumachi 35:699-704. (In Japanese.)
125. Olsen, S. L., D. G. Renlund, J. B. O'Connell, D. O. Taylor, J. E. Lassetter, T. E. Eastburn, E. H. Hammond, and M. R. Bristow. 1993. Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim sulfamethoxazole. Transplantation 56:359-362.
126. Opravil, M., B. Hirschel, A. Lazzarin, A. Heald, M. Pechere, S. Ruttiman, A. Hen, J. von Oberbeck, D. Oertle, G. Praz, D. A. Vuitton, F. Mainini, and R. Luthy. 1995. Once-weekly administration of dapsone-pyrimethamine vs aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Clin. Infect. Dis. 20:531-541.
127. Oz, H. S., and W. T. Hughes. 1997. Novel anu-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone. J. Infect. Dis. 175:901-904.
128. Pagano, L., L. Fianchi, L. Mele, C. Girmenia, M. Offidani, P. Ricci, M. E. Mitra, M. Picardi, C. Caramatti, P. Piccaluga, A. Nosari, M. Buelli, B. Allione, A. Cortelezzi, F. Fabbiano, G. Milone, R. Invernizzi, B. Martino, L. Masini, G. Todeschini, M. A. Capucci, D. Russo, L. Corbata, P. Martino, and A. Del Favero. 2002. Pneumocystis carinii pneumonia in patients with malignant hematological diseases: 10 years' experience of infection in GIMEMA centers. Br. J. Haematol. 117:379-386.
129. Para, M. F., D. Finkelstein, S. Becker, M. Dohn, A. Walawander, and J. R. Black. 2000. Reduced toxicity with gradual initiation of trimethoprim- sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS clinical trials group 268. J Acquir. Immun Defic. Syndr. 24:337-343.
130. Paya, C. V., P. E. Hermans, J. A. Washington II, T. F. Smith, J. P. Anhalt, R. H. Wiesner, and R. A. Krom. 1989. Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin. Proc. 64:555-564.
131. Perera, D. R., K. A. Western, H. D. Johnson, W. W. Johnson, M. G. Schultz, and P. V. Akers. 1970. Pneumocystis carinii pneumonia in a hospital for children. JAMA 214:1074-1079.
132. Phair, J., A. Munoz, R. Detells, R. Kaslow, C. Rinaldo, and A. Saah. 1990. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. N. Engl. J. Med. 322:161-165.
133. Pifer, L. L., W. T. Hughes, S. Stagno, and D. Woods. 1978. Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics 61:35-41.
134. Plotkin, J. S., J. F. Buell, M. J. Njoku, S. Wilson, P. C. Kuo, S. T. Bartlett, C. Howell, and L. B. Johnson. 1997. Methemoglobinemia associated with dapsone treatment in solid organ transplant recipients: a two-case report and review. Liver Transplant. Surg. 3:149-152.
135. Podzamczer, D., A. Salazar, J. Jimenez, E. Consiglio, M. Santin, A. Casanova, G. Rufi, and F. Gudiol. 1995. Intermittent trimethoprim- sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Ann. Intern. Med. 122:755-761.
136. Razavi, B., B. Lund, B. L. Allen, and L. Schlesinger. 2002. Failure of trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis carinii pneumonia with concurrent leucovorin use. Infection 30:41-42.
137. Rizzardi, G. P., A. Lazzarin, M. Musicco, D. Frigerio, M. Maillard, M. Lucchini, and M. Moroni. 1995. Better efficacy of twice monthly than monthly aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. J. Infect. Dis. 31:99-105.
138. Roblot, F., C. Godet, G. Le Moal, B. Garo, M. Faouzi Souala, M. Dary, L. de Gentile, J. A. Gandji, Y. Guimard, C. Lacroix, P. Roblot, and B. Becq-Giraudon. 2002. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur. J. Clin. Microbiol. Infect. Dis. 21:523-531.
139. Rossiter, S. J., D. C. Miller, A. M. Churg, C. B. Carrington, and J. B. Mark. 1979. Open lung biopsy in the immunosuppressed patient. Is it really beneficial? J. Thorac. Cardiovasc. Surg. 77:338-345.
140. Roux, N., R. M. Flipo, B. Cortet, J. J. Lafitte, A. B. Tonnel, B. Duquesnoy, and B. Delcambre. 1996. Pneumocystis carinii pneumonia in rheumatoid arthritis patient treated with methotrexate. A report of two cases. Rev. Rhum. Engl. Ed. 63:453-456.
141. Ruebush, T. K., R. A. Weinstein, R. L. Baehner, D. Wolff, M. S. Bartlett, F. Gonzales-Crussi, A. J. Sulzer, and M. G. Schultz. 1978. An outbreak of Pneumocystis carinii pneumonia in children with acute lymphocytic leukemia. Am. J. Dis. Child. 132:143-148.
142. Saah, A. J., D. R. Hoover, Y. Peng, J. P. Phair, B. Visscher, L. A. Kingsley, L. K. Schrager. 1995. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. JAMA 273:1197-1202.
143. Safrin, S., L. L. Belle, and M. A. Sande. 1994. Adjunctive folinic acid with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk of therapeutic failure and death. J. Infect. Dis. 170:912-917.
144. Salmon-Ceron, D., A. Fontbonne, J. Saba, T. May, F. Raffi, C. Chidiak, O. Patey, J. P. Aboulker, D. Schwartz, and J. L. Vilde. 1995. Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. J. Infect. Dis. 172:656-664.
145. Saukkonen, K., R. Garland, and H. Koziel. 1996. Aerosolized pentamidine as an alternative primary prophylaxis against Pneumocystis carinii pneumonia in adult hepatic and renal transplant recipients. Chest 109:1250-1255.
146. Schiff, D. 1996. Pneumocystis carinii in brain tumor patients: risk factors and clinical features. J. Neurooncol. 27:235-240.
147. Schmatz, D. M., M. A. Powles, D. McFadden, K. Nollstadt, F. A. Bouffard, J. F. Dropinski, P. Liberator, and J. Andersen. 1995. New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat. Antimicrob. Agents Chemother. 39:1320-1323.
148. Schmatz, D. M., M. Powles, D. C. McFadden, L. A. Pittarelli, P. A. Liberator, and J. W. Anderson. 1991. Treatment and prevention of Pneumocystis carinii pneumonia and further elucidation of the Pneumocystis carinii life cycle with 1,3-beta-glucan synthesis inhibitor L-671,329. J. Protozool. 38:151S-153S.
149. Schmatz, D. M., M. A. Romancheck, L. A. Pittarelli, R. E. Schwartz, R. A. Fromtling, K. H. Nolstadt, F. L. Vanmiddlesworth, K. E. Wilson, and M. J. Turner. 1990. Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors. Proc. Natl. Acad. Sci. USA 87:5950-5954.
150. Schneider, M. M. E., A. I. M. Hoepelman, J. Karel, M. E. Schattenkerk, T. L. Nielsen, Y. van der Graaf, J. P. H. J. Frissen, I. M. E. van der Ende, A. F. P. Kolsters, and J. C. C. Borleffs. 1992. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N. Engl. J. Med. 327:1836-1841.
151. Schürmann, D., F. Bergmann, H. Albrecht, J. Padberg, T. Wünsche, T. Grünewald, M. Schürmann, M. Grobusch, M. Vallee, B. Ruf, and N. Suttorp. 2002. Effectiveness of twice-weekly pyrimethamine- sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection. Eur. J. Clin. Microbiol. Infect. Dis. 21:353-361.
152. Sepkowitz, K. A. 1993. Pneumocystis carinii pneumonia in patients without AIDS. Clin. Infect. Dis. 17(Suppl. 2):S416-S422.
153. Sepkowitz, K. A., A. E. Brown, and D. Armstrong. 1995. Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. Arch. Intern. Med. 155:1125-1127.
154. Sepkowitz, K. A., A. E. Brown, E. E. Telzak, S. Gottlieb, and D. Armstrong. 1992. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 267:832-837.
155. Singer, N. G., and W. J. McCune. 1999. Prevention of infectious complications in rheumatic disease patients: immunization, Pneumocystis carinii prophylaxis, and screening for latent infections. Curr. Opin. Rheumatol. 11:173-178.
156. Singer, S. J., R. Tiernan, and E. J. Sullivan. 2000. Interstitial pneumonitis associated with Sirolimus therapy in renal-transplant recipients. N. Engl. J. Med. 343:1815-1816.
157. Sirotzky, L., V. Memoli, J. L. Roberts, and E. J. Lewis. 1978. Recurrent Pneumocystis pneumonia with normal chest roentgenograms. JAMA 240:1513-1515.
158. Slivka, A., P. Y. Wen, W. M. Shea, and J. S. Loeffler. 1993. Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors. Am. J. Med. 94:216-219.
159. Souza, J. P., M. Boeckh, T. A. Gooley, M. E. D. Flowers, and S. W. Crawford. 1999. High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis. Clin. Infect. Dis. 29:1467-1471.
160. Stover, D. E., M. B. Zaman, S. I. Hajdu, M. Lange, J. Gold, and D. Armstrong. 1984. Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunocompromised host. Ann. Intern. Med. 101:1-7.
161. Stringer, J. R., C. B. Beard, R. F. Miller, and A. E. Wakefield. 2002. A new name (Pneumocistis jiroveci) for Pneumocystis from humans. Emerg. Infect. Dis. 8:891-896.
162. Tai, T. L., K. P. O'Rourke, M. McWeeney, C. M. Burke, K. Sheehan, and M. Barry. 2002. Pneumocystis carinii pneumonia following a second infusion of infliximab. Rheumatology 41:951-952.
163. Teira, R., M. Virosta, J. Munoz, Z. Zubero, and J. M. Santamaria. 1997. The safety of pyrimethamine and sulfadoxine, for the prevention of Pneumocystis carinii pneumonia. Scand. J. Infect. Dis. 29:595-596.
164. Torre-Cisneros, J., M. de la Mata, P. Lopez-Cillero, P. Sanchez-Guijo, G. Mine, and G. Pera. 1996. Effectiveness of daily low-dose cotrimoxazole prophylaxis for Pneumocystis carinii pneumonia in liver transplantation-an open clinical trial. Transplantation 62:1519-1521.
165. Torre-Cisneros, J., M. de la Mata, J. C. Pozo, P. Serrano, J. Bricen̄o, G. Solórzano, G. Miño, C. Pera, and P. Sánchez-Guijo. 1999. Randomized trial of weekly sulfadoxine/pyrimethamine vs daily low-dose trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia after liver transplantation. Clin. Infect. Dis. 29:771-774.
166. Torres, R. A., M. Barr, M. Thorn, G. Gregory, S. Kiely, E. Chanin, C. Carlo, and M. Martin. 1993. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. Am. J. Med. 95:573-583.
167. Van der Meer, M. G., and S. L. Brug. 1942. Infection à Pneumocystis chez l'homme et chez les animaux. Ann. Soc. Belge Med. Trop. 22:301-309.
168. Vasconcelles, M. J., M. V. P. Bernardo, C. King, E. A. Weller, and J. H. Antin. 2000. Aerosolized pentamidine as Pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increase risk of other infections. Biol. Blood Marrow Transplant. 6:35-43.
169. Verdier, R. I., D. W. Fitzgerald, W. D. Johnson, and J. W. Pape. 2000. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. Ann. Intern. Med. 132:885-888.
170. Visconti, E., E. Ortona, P. Margutti, S. Marinaci, M. Zolfo, L. P. Celentano, P. Mencarini, A. Siracusano, and E. Tamburrini. 1999. Successful treatment of PCP episodes caused by Pneumocystis carinii with mutant dihydropteroate (DHPS) gene. J. Eukaryot. Microbiol. 46:1358.
171. Vogel, P., J. Mille, L. L. Lowenstine, and A. A. Lackner. 1993. Evidence of horizontal transmission of Pneumocystis carinii pneumonia in simian immunodeficiency virus-infected macaques. J. Infect. Dis. 168:836-843.
172. Walker, D. J., A. E. Wakefield, M. N. Dohn, R. F. Miller, R. P. Baughman, P. A. Hossler, M. S. Bartlett, J. W. Smith, P. Kazanjian, and S. R. Meshnick. 1998. Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure. J. Infect. Dis. 178:1767-1775
173. Walzer, P. D., D. P. Perl, D. J. Krogstad, P. G. Kawson, and M. G. Schultz. 1974. Pneumocystis carinii pneumonia in the United States: epidemiologic, diagnostic, and clinical features. Ann. Intern. Med. 80:83-93.
174. Ward, M. M., and F. Donald. 1999. Pneumocystis carinii pneumonia in patients with connective tissue diseases. Arthritis Rheum. 42:780-789.
175. Weisman, M. H. 2002. What are the risks of biologic therapy in rheumatoid arthritis? An update on safety. J. Rheumatol. 29(Suppl. 65):33-38.
176. Winston, D. J., R. P. Gale, D. V. Meyer, and L. S. Young. 1979. Infectious complications of human bone marrow transplantation. Medicine 58:1-31.
177. Yale, S. H., and A. H. Limper. 1996. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illnesses and prior corticosteroid therapy. Mayo Clin. Proc. 71:5-13.